# Treatment of Diabetes and Depression in Hispanics and African Americans and Its Effect on A1c and Quality of Life.

> **NCT00624013** · PHASE4 · COMPLETED · sponsor: **Charles Drew University of Medicine and Science** · enrollment: 89 (actual)

## Conditions studied

- Diabetes
- Depression

## Interventions

- **DRUG:** sertraline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00624013
- **Lead sponsor:** Charles Drew University of Medicine and Science
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2017-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00624013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00624013, "Treatment of Diabetes and Depression in Hispanics and African Americans and Its Effect on A1c and Quality of Life.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00624013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*